A word from the CEO: 2015 in review

NeuroQuant_2015_infographic1.png2015 was an incredible year for Cortechs.ai, with the team continuing to build on the momentum we started in 2014. During the year, we experienced remarkable growth in our business, added many significant new customers and expanded our strategic business partnerships.

With over 100,000 brains analyzed using NeuroQuant, it is exciting to watch the growth indicating an increased acceptance and realized importance of using quantitative imaging for the assessment of neurological disorders. During 2015, we established NeuroQuant as the most proven and most accurate quantitative imaging solutions and enjoyed worldwide support within hospitals, universities, radiology centers, clinical and research practices and military hospitals. These facilities see and understand the value of NeuroQuant’s volumetric measurements of subcortical structures aiding in the assessment of a variety of clinical disciplines, from dementia, through epilepsy, multiple sclerosis, traumatic brain injuries and brain development.

In the middle of 2015 we released NeuroQuant 2.0, providing significant additions and improvements, among them, new and improved output reports for ages 3 years to 100, the advanced Dynamic Atlas™ segmentation and registration technology, increased accuracy and precision of brain segmentation, and operating system independence. Toward the end of 2015, we expanded NeuroQuant 2.0 to include productivity enhancing capabilities such as the use of parallel imaging on GE, Philips and Siemens 3.0 T scanners, providing faster scan times, the addition of Toshiba Titan 3T scanner compatibility and PowerScribe 360 integration. Click on the infographic to the right to see a better overall picture of 2015’s developments

With these expanded capabilities NeuroQuant continues to be the paramount solution for the assessment of neurological conditions. From brain development to Alzheimer’s, multiple sclerosis, epilepsy and brain trauma, NeuroQuant helps enhance the quality of patient care. As always, we welcome feedback and ideas for improvement from anybody that wants to share it with us.

2015 was a great year, and we are thrilled to see what unfolds for 2016. Stay tuned – more exciting developments are happening and we look forward to sharing them with you!

Guri Stark, CEO
Cortechs.ai

More Resources

10/30/2026

What to Expect at the Cortechs.ai Booth at RSNA 2026

Visit Cortechs.ai at RSNA 2026, Booth 5107. See Cortechs Connect, FDA-cleared NeuroQuant PET and live demos of our AI quantitative imaging tools.

10/14/2026

Cortechs.ai and CARPL.ai Partner to Expand Global Access to AI-Powered Imaging Solutions

Cortechs.ai joins CARPL.ai’s enterprise AI ecosystem to expand access to quantitative imaging solutions worldwide.

10/10/2026

World Mental Health Day: Why Brain Health and Mental Health Belong Together

Behind every brain scan is a person. Here’s why their voice matters.

09/30/2026

Today’s Examination Becomes Tomorrow’s Baseline: The Benefits of Performing Quantitative Analysis on Every Brain MRI

A single brain MRI shows where a patient is today. A quantitative baseline can help show how the brain changes over time.

09/18/2026

What a Head CT Can and Can’t Tell You About a Concussion

For Concussion Awareness Day, learn how quantitative CT analysis can help measure subtle structural changes and support follow-up after traumatic brain injury.

09/09/2026

Prostate Cancer Awareness Month: Finding the Cancer That Matters

How quantitative MRI can bring greater clarity to decisions across the prostate cancer journey.
Scroll to Top